Skip to main content

Table 3 Association of the selected SNPs in IL1A with CRC risk after stratified analysis by gender

From: IL1A polymorphisms is a risk factor for colorectal cancer in Chinese Han population: a case control study

SNP_ID

Genotypes

Male

OR (95% CI)

p a

Female

OR (95% CI)

p b

Controls, n(%)

Patients, n(%)

Controls, n(%)

Patients, n(%)

rs3783550

 

G/G

113 (42.6%)

62 (43.7%)

1.00

 

93 (47.0%)

41 (39.0%)

1.00

 

Codominant

G/T

123 (46.4%)

63 (44.4%)

0.85 (0.53–1.38)

0.800

89 (45.0%)

48 (45.7%)

1.22 (0.73–2.04)

0.096

T/T

29 (10.9%)

17 (12.0%)

0.96 (0.47–1.98)

 

16 (8.1%)

16 (15.2%)

2.41 (1.09–5.34)

 

Dominant (ref: G/G)

G/T-T/T

152 (57.4%)

80 (56.3%)

0.88 (0.56–1.38)

0.560

105 (53.0%)

64 (61.0%)

1.40 (0.86–2.27)

0.180

Recessive (ref: G/G + G/T)

T/T

29 (10.9%)

17 (12.0%)

1.05 (0.53–2.06)

0.900

16 (8.1%)

16 (15.2%)

2.17 (1.03–4.60)

0.043

rs3783546

 

G/G

113 (42.8%)

62 (43.4%)

1.00

 

93 (47.2%)

42 (40.0%)

1.00

 

Codominant

G/C

122 (46.2%)

65 (45.5%)

0.87 (0.54–1.40)

0.850

88 (44.7%)

48 (45.7%)

1.21 (0.72–2.01)

0.170

C/C

29 (11.0%)

16 (11.2%)

0.92 (0.44–1.90)

 

16 (8.1%)

15 (14.3%)

2.18 (0.97–4.85)

 

Dominant (ref: G/G)

G/C-C/C

151 (57.2%)

81 (56.6%)

0.88 (0.56–1.38)

0.580

104 (52.8%)

63 (60.0%)

1.35 (0.83–2.20)

0.220

Recessive (ref: G/G + G/C)

C/C

29 (11.0%)

16 (11.2%)

0.98 (0.49–1.95)

0.960

16 (8.1%)

15 (14.3%)

1.98 (0.93–4.21)

0.080

rs2856838

 

G/G

142 (54.0%)

88 (61.5%)

1.00

 

115 (58.1%)

55 (52.4%)

1.00

 

Codominant

G/A

109 (41.4%)

47 (32.9%)

0.68 (0.42–1.10)

0.260

71 (35.9%)

36 (34.3%)

1.06 (0.63–1.77)

0.078

A/A

12 (4.6%)

8 (5.6%)

1.07 (0.39–2.94)

 

12 (6.1%)

14 (13.3%)

2.63 (1.13–6.15)

 

Dominant (ref: G/G)

G/A-A/A

121 (46.0%)

55 (38.5%)

0.72 (0.46–1.14)

0.160

83 (41.9%)

50 (47.6%)

1.27 (0.79–2.06)

0.330

Recessive (ref: G/G + G/A)

A/A

12 (4.6%)

8 (5.6%)

1.24 (0.46–3.36)

0.670

12 (6.1%)

14 (13.3%)

2.58 (1.13–5.87)

0.024

rs1609682

 

G/G

113 (42.6%)

64 (44.8%)

1.00

 

92 (46.7%)

41 (39.4%)

1.00

 

Codominant

G/T

123 (46.4%)

62 (43.4%)

0.81 (0.50–1.30)

0.670

89 (45.2%)

47 (45.2%)

1.18 (0.70–1.98)

0.100

T/T

29 (10.9%)

17 (11.9%)

0.93 (0.45–1.90)

 

16 (8.1%)

16 (15.4%)

2.39 (1.08–5.31)

 

Dominant (ref: G/G)

G/T-T/T

152 (57.4%)

79 (55.2%)

0.83 (0.53–1.31)

0.420

105 (53.3%)

63 (60.6%)

1.36 (0.83–2.21)

0.220

Recessive (ref: G/G + G/T)

T/T

29 (10.9%)

17 (11.9%)

1.03 (0.53–2.04)

0.920

16 (8.1%)

16 (15.4%)

2.20 (1.04–4.65)

0.040

rs3783521

 

A/A

113 (42.6%)

62 (43.7%)

1.00

 

93 (47.0%)

41 (39.0%)

1.00

 

Codominant

G/A

123 (46.4%)

64 (45.1%)

0.86 (0.53–1.38)

0.820

89 (45.0%)

48 (45.7%)

1.22 (0.73–2.04)

0.110

G/G

29 (10.9%)

16 (11.3%)

0.92 (0.44–1.90)

 

16 (8.1%)

16 (15.2%)

2.36 (1.07–5.22)

 

Dominant (ref: A/A)

G/A-G/G

152 (57.4%)

80 (56.3%)

0.87 (0.55–1.37)

0.540

105 (53.0%)

64 (61.0%)

1.39 (0.86–2.26)

0.180

Recessive (ref: A/A + G/A)

G/G

29 (10.9%)

16 (11.3%)

0.99 (0.50–1.97)

0.980

16 (8.1%)

16 (15.2%)

2.13 (1.01–4.49)

0.048

  1. SNP Single nucleotide polymorphism, OR Odds ratio; 95% CI: 95% confidence interval
  2. pa-values were calculated by logistic regression analysis with adjustment for age in males
  3. pb-values were calculated by logistic regression analysis with adjustment for age in females
  4. Bold italics indicates the SNP with statistical significance (p < 0.05)